APOPTOSIS ROLE IN FORMING RADIOIODINE RESISTANCE IN DIFFERENTIATED THYROID CANCER
According to studies, 25-66% of patients with metastatic highly differentiated thyroid cancer (DTC) develop partial or complete resistance of metastases to therapy with radioactive iodine.The review discusses the molecular mechanisms for Stabilizers the involvement of various apoptosis proteins in the formation of radioiodine resistance in patients